Download FREE Report Sample
Download Free sampleGnRH antagonists are synthetic analogs of GnRH that bind to the GnRH receptors in the pituitary, rapidly suppressing the secretion of gonadotropins.
GnRH Receptor Antagonists Market contains market size and forecasts of GnRH Receptor Antagonists in global, including the following market information:
Global GnRH Receptor Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global GnRH Receptor Antagonists Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five GnRH Receptor Antagonists companies in 2021 (%)
The global GnRH Receptor Antagonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Peptides Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GnRH Receptor Antagonists include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals and Jiangsu Hengrui Medicine Co. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
surveyed the GnRH Receptor Antagonists manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GnRH Receptor Antagonists Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GnRH Receptor Antagonists Market Segment Percentages, by Type, 2021 (%)
Peptides
Small Molecules
Global GnRH Receptor Antagonists Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GnRH Receptor Antagonists Market Segment Percentages, by Application, 2021 (%)
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others
Global GnRH Receptor Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global GnRH Receptor Antagonists Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GnRH Receptor Antagonists revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies GnRH Receptor Antagonists revenues share in global market, 2021 (%)
Key companies GnRH Receptor Antagonists sales in global market, 2017-2022 (Estimated), (K Units)
Key companies GnRH Receptor Antagonists sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
